Home > Boards > US Listed > Biotechs > Cassava Sciences Inc (SAVA)

BTW, There is a Short on Yahoo who

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
purefreewater Member Profile
 
Followed By 58
Posts 3,488
Boards Moderated 0
Alias Born 09/27/09
160x600 placeholder
Cassava Sciences’ Phase 2b Clinical Results in Alzheimer’s Selected as Late-Breaking News at CTAD 2020 GlobeNewswire Inc. - 9/30/2020 8:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2020 4:50:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/21/2020 4:02:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2020 5:26:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2020 5:16:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 4:03:06 PM
Cassava Sciences Announces Final Results of a Phase 2b Clinical Study of Sumifilam in Patients with Alzheimer’s Disease GlobeNewswire Inc. - 9/14/2020 7:15:10 AM
Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET GlobeNewswire Inc. - 9/11/2020 4:01:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2020 4:07:28 PM
Cassava Sciences to Present at H.C. Wainwright’s 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 8:15:10 AM
Cassava Sciences Announces New Patent Grant GlobeNewswire Inc. - 9/3/2020 8:15:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2020 5:01:15 PM
Cassava Sciences Announces Lead Drug Candidate PTI-125 Is Assigned the Chemical Drug Name ‘sumifilam’ by USAN GlobeNewswire Inc. - 8/24/2020 8:15:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2020 8:30:52 AM
Cassava Sciences Announces Second Quarter 2020 Financial Results and Mid-year Business Review GlobeNewswire Inc. - 8/12/2020 8:15:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/15/2020 4:52:29 PM
Cassava Sciences to Give Keynote Presentation on SavaDx at a Scientific Conference GlobeNewswire Inc. - 7/9/2020 4:01:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 4:45:20 PM
Cassava Sciences Added to Russell Indexes and Provides Phase 2b Study Update GlobeNewswire Inc. - 6/16/2020 8:15:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2020 5:30:11 PM
Cassava Sciences Announces Presentation at the Jefferies Virtual Healthcare Conference and Provides Updates Regarding Phase 2... GlobeNewswire Inc. - 6/3/2020 8:15:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 8:21:10 AM
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary Endpoint GlobeNewswire Inc. - 5/15/2020 8:15:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2020 4:09:54 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2020 4:12:00 PM
purefreewater   Saturday, 04/01/17 11:57:50 PM
Re: None
Post # of 1499 
BTW, There is a Short on Yahoo who is posting that the company will need to R/S

The company will not need to R/S ...... the PPS will be way above $ 1.00 soon

and they have plenty of cash !


There will be no need to R/S












Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences